NDC 68084-071-11
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68084-071
- Requested NDC
- 68084-071-11
- Package NDCs from labels
- 68084-071-11
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68084-071-01 | EA - Each | 68084-071 | abda5d4e-4929-40fc-a44f-601284f23afc | 1 | 2012-07-24 |
| 68084-071-11 | EA - Each | 68084-071 | d18ec8b4-516f-4a93-b1fe-eefcf2f23fd8 | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciprofloxacin | CIPROFLOXACIN | Teva Pharmaceuticals USA, Inc. | 3e4402d4-e0d3-9846-3e81-ed46f34137fe | 2024-10-30 | Boxed warning, Warnings, Adverse reactions | ANDA076794 |
| Ciprofloxacin | CIPROFLOXACIN | NuCare Pharmaceuticals,Inc. | b0136d72-0869-2da0-e053-2995a90af70a | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | ANDA076794 |
| Ciprofloxacin | CIPROFLOXACIN | NuCare Pharmaceuticals,Inc. | b064286b-fedc-be68-e053-2995a90aae52 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | ANDA076794 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.